United Therapeutics reported $286.3M in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Amarin AMRN:US $ -28.31M 44.44M
Ardelyx ARDX:US $ -27.81M 7.47M
Baxter International BAX:US $ 163M 183M
Bayer BAYN:GR 4.21B 2.19B
Biocryst Pharmaceuticals BCRX:US $ -49.96M 53.62M
Biogen BIIB:US $ 610.7M 23.6M
Biomarin Pharmaceutical BMRN:US $ 137.33M 203.21M
Emergent Biosolutions EBS:US $ 6.4M 271M
Esperion Therapeutics ESPR:US $ -42989000 12.64M
Gilead Sciences GILD:US $ 197M 743M
GlaxoSmithKline GSK:LN 2.8B 1.91B
Halozyme Therapeutics HALO:US $ 75.67M 19.14M
Insmed INSM:US $ -89833000 9.24M
Intercept Pharmaceuticals ICPT:US $ -10.27M 10.59M
Intra Cellular Therapies ITCI:US $ -72.66M 13.34M
Johnson & Johnson JNJ:US $ 5862M 1026M
Lexicon Pharmaceuticals LXRX:US -23380000 1.95M
Moderna Inc MRNA:US 4.23B 1.18B
Pfizer PFE:US $ 9873M 5297M
Ptc Therapeutics PTCT:US $ -86.52M 1.79M
Regeneron Pharmaceuticals REGN:US $ 1258.5M 1381.2M
Sangamo Biosciences SGMO:US $ -45.26M 5.36M
Sarepta Therapeutics SRPT:US $ -86.88M 18.93M
Seattle Genetics SGEN:US $ -133.05M 39.02M
Teva Pharmaceutical TEVA:IT -713000000 791M
United Therapeutics UTHR:US $ 286.3M 116.5M
Vertex Pharmaceuticals VRTX:US $ 1040.9M 163.18M